EA-2098

EA-2098 is a chemical compound that belongs to the class of opioid analgesics. It is a potent analgesic drug that is structurally related to etorphine, a semi-synthetic opioid possessing an analgesic potency approximately 1,000–3,000 times that of morphine. EA-2098 was developed by the pharmaceutical industry in the late 20th century as part of a series of related compounds.

Chemistry

EA-2098 is a derivative of the opioid analgesic etorphine, which itself is a derivative of the naturally occurring opioid alkaloid thebaine. The chemical structure of EA-2098 includes a phenyl ring substituted with a piperidine ring, similar to other opioids. However, unlike many opioids, EA-2098 does not contain a basic nitrogen atom, which is typically a key feature of opioid structure.

Pharmacology

The pharmacology of EA-2098 is similar to that of other opioids. It acts primarily as an agonist at the mu-opioid receptor, which is the primary site of action for the most commonly used opioids. This receptor is involved in the perception of pain and the body's response to it. By binding to this receptor, EA-2098 can produce potent analgesic effects.

Clinical Use

As of now, EA-2098 is not approved for use in humans. Its high potency and potential for abuse make it a candidate for strict regulation. However, it may have potential for use in veterinary medicine, particularly for large animals such as elephants and horses, where its high potency could be beneficial.

See Also

• Opioid
• Etorphine
• Thebaine
• Mu-opioid receptor